Quarterly snapshots from biopharma companies with marketed products, including: Adamas, Amag, Beigene, Clovis, Coherus, Exelixis, Dynavax, Fibrogen, GW, Ocular, Puma.

New hires and promotions in the biopharma industry, including: Fibrogen, Okyo, Xortx.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adaptive Biotechnologies, Cardiacsense, Joimax, Scientia Vascula, Surmodics, Vela Diagnostics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aethlon Medical, Avacta Group, BBI Solutions, Bio-Techne, Btl Industries, Cerner, Cytiva, GW Plastics, Helius Medical Technologies, Hologic, Lrvhealth, Nanostring Technologies, Nanotronics, Nolato, Ortho Regenerative Technologies, Radnet, T2 Biosystems, Xealth, Xenex Disinfection Services.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Beckman Coulter, Boston Scientific, Carmat, Veracyte.

Med-tech firms raising money in public or private financings, including: Ginger, Infermedica, Obsidio, Pavmed, Retina-AI Health, Sight Diagnostics, Tangen Biosciences.

New hires and promotions in the med-tech industry, including: Anika Therapeutics, Innovheart.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Anavex, Catalyst, GSK, Jaguar, Neurorx, Organicell, Redhill, Relief, Tonix, Y-mabs.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamis, Astrazeneca, Aveo, CSL, Daiichi, Galmed, Glaxosmithkline, Immatics, Iovance, Kyowa Kirin, Mirati, Oric, Seattle Genetics, Sab, Som, Veracyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioaegis, Boehringer, Dicerna, Idorsia, Levo, Medicinova, Nordic, Novartis, Personalized Stem Cells, Precigen, Rafael, Tessa.